I am a
Home I AM A Search Login

Papers of the Week


2022


Front Neurol


13

A preliminary trial of botulinum toxin type A in patients with vestibular migraine: A longitudinal fMRI study.

Authors

Oh S-Y, Kang J-J, Kim S, Lee J-M, Kim J-S, Dieterich M
Front Neurol. 2022; 13:955158.
PMID: 35959394.

Abstract

This study aims to investigate the efficacy of botulinum toxin type A (BTX-A) in the prophylactic management of vestibular migraine (VM) and to determine whether this treatment modulates intrinsic functional brain network.